Inventor · disambiguated record
Xiaohui Ma
Also filed as: MA XIAOHUI
16 granted patents·10 pending applications·5 citations·filing 2010–2024
87Inventor score
Files withTASLY PHARMACEUTICAL GROUP CO17JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD3TASLY BIOPHARMACEUTICALS CO LTD3MA XIAOHUI1UNIV NINGXIA1
Top patents by PatentIndex Score
26 records- 0179US12090138B2Pharmaceutical composition containing silybin and VETASLY PHARMACEUTICAL GROUP CO·Filed 2022·Granted Sep 17, 2024·0 cites·8 claims
- 0274US10626077B2Salvianolic acid compound T, preparation method therefor, and use thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2014·Granted Apr 21, 2020·3 cites·13 claims
- 0372US10300030B2Traditional Chinese medicine compositionTASLY PHARMACEUTICAL GROUP CO·Filed 2014·Granted May 28, 2019·1 cites·20 claims
- 0465US10307395B2Pharmaceutical composition containing silybin and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0565US10307396B2Pharmaceutical composition containing silybin, VE and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0665US2025042964A1Method of treating nash using a long-acting mutant human fibroblast growth factorTASLY BIOPHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0761US10507197B2Pharmaceutical composition containing silibininTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Dec 17, 2019·0 cites·20 claims
- 0860US11318112B2Pharmaceutical composition containing silybin and veTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted May 3, 2022·0 cites·18 claims
- 0960US10376491B2Pharmaceutical composition containing silibinin and pueraria root extractTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
- 1059US12152059B2Method of treating nash using a long-acting mutant human fibroblast growth factorTASLY BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·8 claims
- 1159US2023390353A1Pharmaceutical composition for treating myocardial ischemia and preparation method thereforTASLY PHARMACEUTICAL GROUP CO·Filed 2022·Application pending·0 cites
- 1257US10071989B2Substituted cinnamamide derivative, preparation method and use thereofMA XIAOHUI·Filed 2012·Granted Sep 11, 2018·1 cites·10 claims
- 1357US2025304587A1Wee1 inhibitor, preparation therefor and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1457US2024217946A1Antidepressant and anxiolytic substituted cinnamamide compoundTASLY PHARMACEUTICAL GROUP CO·Filed 2022·Application pending·0 cites
- 1556US2025034151A1Wee1 inhibitor, preparation therefor, and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1655US9889093B2Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 1753US2024199619A1Wee1 inhibitor and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1848US11098065B2Preparation method of an energetic coordination compound with 5-methyltetrazoleUNIV NINGXIA·Filed 2020·Granted Aug 24, 2021·0 cites·9 claims
- 1946US2017224623A1Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2017·Application pending·0 cites
- 2046US2017224622A1Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2017·Application pending·0 cites
- 2145US2021038668A1Traditional chinese medicine composition for preventing and/or treating ischemic reperfusion injuryTASLY PHARMACEUTICAL GROUP CO·Filed 2019·Application pending·0 cites
- 2242US11491173B2Pharmaceutical composition and application thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2019·Granted Nov 8, 2022·0 cites·19 claims
- 2340US10874636B2Application of substituted cinnamamide derivatives in preparation of anti-anxiety medicationTASLY PHARMACEUTICAL GROUP CO·Filed 2017·Granted Dec 29, 2020·0 cites·9 claims
- 2437US10376490B2Pharmaceutical composition containing silybinTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·17 claims
- 2532US11655308B2HM-3 fusion protein and application thereofTASLY BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted May 23, 2023·0 cites·11 claims
- 2628US2012041062A1Compound of salvianolic acid l, preparation method and use thereofZHOU SHUIPING·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaohui Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →